SCHEMBL5116732

SCHEMBL5116732

CC(C)(C)Nc1c(-c2ccc(C#C[Si](C)(C)C)s2)nc2ccccn12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA1B P35368 1/20 0.55
TOP2A P11388 1/20 0.47
BRD4 O60885 1/20 0.47
TRIM24 O15164 1/20 0.47
SALL4 Q9UJQ4 1/20 0.47
TRIM33 Q9UPN9 1/20 0.47
MAPT P10636 4/20 0.46
GAA P10253 4/20 0.46
PKM P14618 2/20 0.46
TP53 P04637 1/20 0.46
PKLR P30613 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HDAC4 P56524 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45
BACE1 P56817 6/20 0.44
BACE2 Q9Y5Z0 6/20 0.44
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5128705 0.86 PKM (0.55) ADRA1BTOP2ABRD4TRIM24SALL4
SCHEMBL5118071 0.85 ADRA1B (0.51) ADRA1BTOP2ABRD4TRIM24SALL4
SCHEMBL5116403 0.85 ADRA1B (0.58) ADRA1BTOP2ABRD4TRIM24SALL4
Hydrochloric Acid SCHEMBL5114555 0.85 PKM (0.54) ADRA1BTOP2ABRD4TRIM24SALL4
SCHEMBL5120958 0.85 ADRA1B (0.53) ADRA1BTOP2ABRD4TRIM24SALL4
SCHEMBL5263543 0.85 ADRA1B (0.53) ADRA1BTOP2ABRD4TRIM24SALL4
SCHEMBL5128134 0.85 BRD4 (0.48) ADRA1BBRD4SALL4MAPTGAA
Hydrochloric Acid SCHEMBL5127777 0.85 ADRA1B (0.50) ADRA1BTOP2ABRD4TRIM24SALL4
Hydrochloric Acid SCHEMBL5116906 0.85 ADRA1B (0.50) ADRA1BTOP2ABRD4TRIM24SALL4
Hydrochloric Acid SCHEMBL5128441 0.84 ADRA1B (0.52) ADRA1BTOP2ABRD4TRIM24SALL4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7420056-B2 Substituted bicyclic imidazo-3-ylamine compounds GRUENENTHAL GMBH (DE) 2008-09-02 US disclosed
US-20070155965-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS GRUENENTHAL GMBH. (DE) 2007-07-05 US disclosed
EP-1791840-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS Grünenthal GmbH (DE) 2007-06-06 EP disclosed
WO-2006029980-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS Grünenthal GmbH (DE) 2006-03-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155965-A1 SUBSTITUTED BICYCLIC IMIDAZO-3-YLAMINE COMPOUNDS AADAC, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, PAICS ADRA1B 609/4885TOP2A 2972/4885BRD4 83/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.